# Prostate Cancer Diagnostic e-Trigger Manual

February, 2024

## Prostate Cancer Diagnostic e-Trigger Criteria

1.  Identify all patient records with prostate specific antigen (PSA)
    tests, defined as:

(patients ages 40--70 with PSA tests dated from January 1, 2009 to
December 31, 2009 with a value of 4.1 to 15 ng/mL[^1] *and* no PSA
greater than 4.1 ng/mL[^2] in the two years prior *and* who are alive 90
days after the diagnostic clue)

## Clinical Exclusion Criteria

2.  Previous prostate cancer (**any prior diagnosis**)

    a.  Patients with prostate cancer[^3]

3.  Terminal illnesses or recent major diagnoses within **one year
    before or 90 days after** the diagnostic clue

    a.  Acute Leukemia only[^leukemia]

    b.  Hepatocellular cancer[^liver_cancer]

    c.  Biliary cancer[^biliary_cancer]

    d.  Esophageal cancer[^esophageal_cancer]

    e.  Gastric cancer[^gastric_cancer]

    f.  Head and Neck cancer: cancer in the tongue,[^9] major salivary
        glands,[^10] gingivae,[^11] floor of the mouth,[^12] other sites
        within the oral cavity,[^13] oral,[^14] nasal,[^15]
        hypopharynx,[^16] nose and sinuses,[^17] larynx,[^18] or with
        metastases to neck nodes from unknown origin[^19]

    g.  Patients who had brain cancer[^brain_cancer]

    h.  Patients who had Kidney cancer[^21]

    i.  Patients who had ovarian cancer[^ovarian_cancer]

    j.  Patients who had pancreatic cancer[^pancreatic_cancer]

    k.  Patients who had lung cancer[^24]

4.  Patients who have ever **in the past or within 90 days after** the
    diagnostic clue had an encounter for hospice/palliative care[^hospice]

5.  Patients who were diagnosed with prostatitis **within 30 days
    prior** to diagnostic clue[^26]

6.  Patients who had a prostate biopsy performed **in the 2 years
    prior** to diagnostic clue[^27]

## Expected Follow-up Criteria

1.  Patients who had a urology consult[^28] requested or completed
    > **within 90 days after** the diagnostic clue.

2.  Patients who were diagnosed with prostatitis[^26] **within 90 days
    > after** the diagnostic clue

3.  Patients who had a prostate biopsy[^27] performed **within 90 days
    > after** the diagnostic clue

4.  Patients who had a second evaluation of PSA[^28] **within 90 days**
    > after the diagnostic clue

**High risk group:** Patients with the diagnostic clue during the time
of interest, not meeting any exclusion criteria, and having none of the
outcomes.






[^1]: 

[^2]: 

[^3]: ICD-10 prostate: C61

[^9]: ICD-10 tongue: C02.9 (unspecified)

[^10]: ICD-10 salivary gland: C08.9

[^11]: ICD-10 gingivae: D00.03

[^12]: ICD-10 floor of the mouth: C04

[^13]: ICD-10 other sites within the oral cavity: C06.89

[^14]: ICD-10 code mouth: C06.9 (unspecified)

[^15]: ICD-10 code nasal cavity: C30.0

[^16]: ICD-10 code hypopharynx (unspecified): C13.9

[^17]: ICD-10 code nasal cavity: C30.0

[^18]: ICD-10 larynx: C32.9

[^19]: 

[^21]: ICD-10 kidney: C64.9

[^24]: ICD-10 lung: C34.0 to C34.3, C34.8, C34.9, C78.00, C78.01, C78.02;
ICD-9: 162.0, 162.2x, 162.3x, 162.4x, 162.5x, 162.8x, 162.9x, 163.xx,
197.0, 197.2, 197.3 (where 'x' is any value)

[^26]: ICD-10 acute prostatitis: N41.0

[^27]: CPT prostate biopsy: 55700

[^28]: CPT urology evaluation and management: 99202--99499

